Nail incorporation kinetics of terbinafine in onychomycosis patients
- 1 September 1995
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 20 (5), 377-383
- https://doi.org/10.1111/j.1365-2230.1995.tb01353.x
Abstract
Patients with toe-nail onychomycosis were treated with terbinafine (250 mg daily, n = 20) for either 6 or 12 weeks in a randomized double-blind study. Plasma and distal nail clippings were taken before initiation of therapy and 1, 6, 12, 18, 24, 36 and 48 weeks thereafter. Analytical data of terbinafine extracted from nail clippings or plasma were obtained by high-performance liquid chromatography (HPLC). Nail extracts and isolated HPLC terbinafine peaks were analysed using a combined gas chromatography-mass spectroscopy system (GC-MS) for unequivocal identification of the drug. Terbinafine could be detected in the distal nail in the majority of the patients within 1 week of starting therapy. Maximum terbinafine levels of 0.52 and 1.01 micrograms/g were measured after 18 weeks in the 6- and 12-week treatment groups, respectively. While plasma levels decreased rapidly after termination of therapy terbinafine was detected in the nails as long as 30 weeks (6 weeks treatment) and 36 weeks (12 weeks treatment) after termination of therapy at a range of 0.28-0.19 microgram/g. The drug concentrations measured at all time points are well above the minimum inhibitory concentration (MIC) for dermatophytes and other fungi. These data suggest that the drug reaches the nail plate rapidly and persists there for several months after cessation of active treatment.Keywords
This publication has 11 references indexed in Scilit:
- Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycosesBritish Journal of Dermatology, 1994
- Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 daysClinical and Experimental Dermatology, 1994
- Pharmacokinetics of terbinafine in the nailBritish Journal of Dermatology, 1992
- Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus surveyBritish Journal of Dermatology, 1992
- Allylamine Antifungal DrugsPublished by Springer Nature ,1992
- Pharmacokinetics of terbinafine in the nailJournal of Dermatological Treatment, 1992
- Pharmacokinetics of Lamisil® in humansJournal of Dermatological Treatment, 1990
- Nail matrix kinetics of oral terbinafine in onychomycosis and normal nailsJournal of Dermatological Treatment, 1990
- Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuumMycoses, 1989
- Antifungal activity of the allylamine derivative terbinafine in vitroAntimicrobial Agents and Chemotherapy, 1987